The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Biofilm of Candida albicans : formation, regulation and resistance
Abstract
Candida albicans is the most common human fungal pathogen, causing infections that range from mucous membranes to systemic infections. The present article provides an overview of C. albicans, with the production of biofilms produced by this fungus, as well as reporting the classes of antifungals used to fight such infections, together with the resistance mechanisms to these drugs. Candida albicans is highly adaptable, enabling the transition from commensal to pathogen due to a repertoire of virulence factors. Specifically, the ability to change morphology and form biofilms is central to the pathogenesis of C. albicans. Indeed, most infections by this pathogen are associated with the formation of biofilms on surfaces of hosts or medical devices, causing high morbidity and mortality. Significantly, biofilms formed by C. albicans are inherently tolerant to antimicrobial therapy, so the susceptibility of C. albicans biofilms to current therapeutic agents remains low. Therefore, it is difficult to predict which molecules will emerge as new clinical antifungals. The biofilm formation of C. albicans has been causing impacts on susceptibility to antifungals, leading to resistance, which demonstrates the importance of research aimed at the prevention and control of these clinical microbial communities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“…procedures, catheters, total parenteral nutrition, mechanical ventilation, prolonged hospitalization, treatment with steroids, hyperglycaemia, use of broad-spectrum antibiotics for long periods and intake of subinhibitory concentrations of antifungals (Pfaller and Diekema 2007; Ha et al. 2011).”
BackgroundMicrobial Biofilms: from Ecology to Molecular Genetics
Davey, M. E., & O'toole, G. A. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.847-867.2000 · Cited by 3,086
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
Ramage, G., Saville, S. P., Wickes, B. L., & López-Ribot, J. L. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5459-5463.2002 · Cited by 701
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Fava, N. M. N., Soares, R. M., Scalia, L. A. M., Kalapothakis, E., Pena, I. F., Vieira, C. U., Faria, E. S. M., Cunha, M. J., Couto, T. R., & Cury, M. C. (2013) · BioMed Research International · doi:10.1155/2013/875048 · Cited by 602
The superficial life of microbes
Kolter, R., & Greenberg, E. P. (2006) · Nature · doi:10.1038/441300a · Cited by 555
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
How to build a biofilm: a fungal perspective
Blankenship, J. R., & Mitchell, A. P. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.10.003 · Cited by 530
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Pathogenesis of Candida albicans biofilm
Tsui, C., Kong, E. F., & Jabra-Rizk, M. A. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw018 · Cited by 481
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Uppuluri, P., Chaturvedi, A. K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A. K., Köhler, J. R., Kadosh, D., & Lopez-Ribot, J. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000828 · Cited by 432
Quorum sensing in fungi – a review
Albuquerque, P., & Casadevall, A. (2012) · Medical Mycology · doi:10.3109/13693786.2011.652201 · Cited by 431
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411
Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Pathogenesis and treatment of oral candidosis
Williams, D., & Lewis, M. (2011) · Journal of Oral Microbiology · doi:10.3402/jom.v3i0.5771 · Cited by 356
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Biofilm Matrix Regulation by Candida albicans Zap1
Nobile, C. J., Nett, J. E., Hernday, A. D., Homann, O. R., Deneault, J.-S., Nantel, A., Andes, D. R., Johnson, A. D., & Mitchell, A. P. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000133 · Cited by 337
A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Amphotericin B-Induced Oxidative Damage and Killing of Candida albicans
Sokol-Anderson, M. L., Brajtburg, J., & Medoff, G. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.1.76 · Cited by 287
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Jones, M. E., Draghi, D. C., Thornsberry, C., Karlowsky, J. A., Sahm, D. F., & Wenzel, R. P. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-14 · Cited by 269
Xiao, L., Madison, V., Chau, A. S., Loebenberg, D., Palermo, R. E., & McNicholas, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.568-574.2004 · Cited by 267
Azole antifungals: 35 years of invasive fungal infection management
Allen, D., Wilson, D., Drew, R., & Perfect, J. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1032939 · Cited by 255
Update on antifungal resistance in Aspergillus and Candida
Arendrup, M. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12513 · Cited by 240
Effect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234
Farnesol-Induced Apoptosis in Candida albicans
Shirtliff, M. E., Krom, B. P., Meijering, R. A. M., Peters, B. M., Zhu, J., Scheper, M. A., Harris, M. L., & Jabra-Rizk, M. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01551-08 · Cited by 230
Rajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. J., & Ramage, G. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.018 · Cited by 228
Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S., Williams, J., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219
Candida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207
Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206
Agarwal, A. K., Rogers, P. D., Baerson, S. R., Jacob, M. R., Barker, K. S., Cleary, J. D., Walker, L. A., Nagle, D. G., & Clark, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306291200 · Cited by 204
Tumbarello, M., Fiori, B., Trecarichi, E. M., Posteraro, P., Losito, A. R., De Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., & Posteraro, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033705 · Cited by 197
Design and optimization of highly-selective fungal CYP51 inhibitors
Hoekstra, W. J., Garvey, E. P., Moore, W. R., Rafferty, S. W., Yates, C. M., & Schotzinger, R. J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.068 · Cited by 192
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in Applied Microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 184
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
An expanded regulatory network temporally controls C andida albicans biofilm formation
Fox, E. P., Bui, C. K., Nett, J. E., Hartooni, N., Mui, M. C., Andes, D. R., Nobile, C. J., & Johnson, A. D. (2015) · Molecular Microbiology · doi:10.1111/mmi.13002 · Cited by 173
Fungal quorum sensing molecules: Role in fungal morphogenesis and pathogenicity
Wongsuk, T., Pumeesat, P., & Luplertlop, N. (2016) · Journal of Basic Microbiology · doi:10.1002/jobm.201500759 · Cited by 169
Nett, J. E., Sanchez, H., Cain, M. T., Ross, K. M., & Andes, D. R. (2011) · Eukaryotic Cell · doi:10.1128/ec.05126-11 · Cited by 168
Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165
Rogers, P. D., & Barker, K. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1220-1227.2003 · Cited by 159
Holmes, A. R., Lin, Y.-H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., Tanabe, K., Monk, B. C., & Cannon, R. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00463-08 · Cited by 159
Nailis, H., Kucharíková, S., Řičicová, M., Van Dijck, P., Deforce, D., Nelis, H., & Coenye, T. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-114 · Cited by 157
Fungal vaccines, mechanism of actions and immunology: A comprehensive review
Nami, S., Mohammadi, R., Vakili, M., Khezripour, K., Mirzaei, H., & Morovati, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.075 · Cited by 143
Immunotherapeutic approaches to treatment of fungal diseases
Armstrong-James, D., Brown, G. D., Netea, M. G., Zelante, T., Gresnigt, M. S., van de Veerdonk, F. L., & Levitz, S. M. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30442-5 · Cited by 135
Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions
Mitchell, K. F., Zarnowski, R., & Andes, D. R. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005828 · Cited by 132
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 126
“Persisters”: Survival at the Cellular Level
Dawson, C. C., Intapa, C., & Jabra‐Rizk, M. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002121 · Cited by 125
The ABCs of Candida albicans multidrug transporter Cdr1
Prasad, R., Banerjee, A., Khandelwal, N. K., & Dhamgaye, S. (2015) · Eukaryotic Cell · doi:10.1128/ec.00137-15 · Cited by 123
Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole
Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P. A., & Thevissen, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-11 · Cited by 119
Castanheira, M., Deshpande, L. M., Davis, A. P., Rhomberg, P. R., & Pfaller, M. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-17 · Cited by 117
Fox, E. P., & Nobile, C. J. (2012) · Transcription · doi:10.4161/trns.22281 · Cited by 114
Nicholls, S., MacCallum, D. M., Kaffarnik, F., Selway, L., Peck, S. C., & Brown, A. J. P. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.08.010 · Cited by 114
Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole
Mateus, C., Crow, S. A., & Ahearn, D. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3358-3366.2004 · Cited by 113
The Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion
Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., & Lopez-Ribot, J. L. (2010) · Eukaryotic Cell · doi:10.1128/ec.00111-10 · Cited by 110
Candida albicans biofilm formation in a new in vivo rat model
Řičicová, M., Kucharíková, S., Tournu, H., Hendrix, J., Bujdáková, H., Eldere, J. V., Lagrou, K., & Dijck, P. V. (2009) · Microbiology · doi:10.1099/mic.0.033530-0 · Cited by 110
Quorum-sensing in yeast and its potential in wine making
Avbelj, M., Zupan, J., & Raspor, P. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7758-3 · Cited by 104
Echinocandins — An Advance in the Primary Treatment of Invasive Candidiasis
Walsh, T. J. (2002) · New England Journal of Medicine · doi:10.1056/nejme020142 · Cited by 100
Management of invasive fungal infections: a role for polyenes
Chandrasekar, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq479 · Cited by 100
CandidaBiofilms and the Host: Models and New Concepts for Eradication
Tournu, H., & Dijck, P. V. (2011) · International Journal of Microbiology · doi:10.1155/2012/845352 · Cited by 97
Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B
Baillie, G. S., & Douglas, L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2146 · Cited by 95
Global Identification of Biofilm-Specific Proteolysis in Candida albicans
Winter, M. B., Salcedo, E. C., Lohse, M. B., Hartooni, N., Gulati, M., Sánchez, H., Takagi, J., Hube, B., Andes, D. R., Johnson, A. D., et al. (2016) · mBio · doi:10.1128/mbio.01514-16 · Cited by 93
Farnesol signalling in Candida albicans – more than just communication
Polke, M., Leonhardt, I., Kurzai, O., & Jacobsen, I. D. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1337711 · Cited by 93
Pathogenic factors inCandidabiofilm-related infectious diseases
Hirota, K., Yumoto, H., Bayarmagnai, S., Matsuo, T., Ichikawa, T., & Miyake, Y. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 91
Antifungal drug resistance: do molecular methods provide a way forward?
Perlin, D. S. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283321ce5 · Cited by 89
A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D. (2014) · mBio · doi:10.1128/mbio.01201-14 · Cited by 87 · cited 1×
“Overexpression of Ume6 reduces dispersion, whereas overexpression of Nrg1 or Pes1 increases the number of cells released from the biofilm (Uppuluri et al. 2010a, 2010b; Nobile et al. 2014).”
BackgroundZhu, J., Krom, B. P., Sanglard, D., Intapa, C., Dawson, C. C., Peters, B. M., Shirtliff, M. E., & Jabra‐Rizk, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028830 · Cited by 83
Farnesol, a Fungal Quorum-Sensing Molecule Triggers Apoptosis in Human Oral Squamous Carcinoma Cells
Scheper, M. A., Shirtliff, M. E., Meiller, T. F., Peters, B. M., & Jabra‐Rizk, M. A. (2008) · Neoplasia · doi:10.1593/neo.08444 · Cited by 80
Candidemia and invasive candidiasis: A review of the literature for the burns surgeon
Ha, J. F., Italiano, C. M., Heath, C. H., Shih, S., Rea, S. M., & Wood, F. M. (2010) · Burns · doi:10.1016/j.burns.2010.01.005 · Cited by 77
New insights on the development of fungal vaccines: from immunity to recent challenges
Medici, N. P., & Poeta, M. D. (2015) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150335 · Cited by 73
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 72
Cottier, F., & Mühlschlegel, F. A. (2011) · International Journal of Microbiology · doi:10.1155/2012/351832 · Cited by 68
Faria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. P., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2194-8 · Cited by 64
Bamford, C. V., Nobbs, A. H., Barbour, M. E., Lamont, R. J., & Jenkinson, H. F. (2014) · Microbiology · doi:10.1099/mic.0.083378-0 · Cited by 61
Microbial biofilms: e pluribus unum
Nobile, C. J., & Mitchell, A. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.035 · Cited by 59
The development of oral vaccines based on live attenuated Salmonella strains
Chatfield, S. N., Roberts, M., Londoño, P., Cropley, I. M., Douce, G. R., & Gordon Dougan, B. (1993) · FEMS Immunology & Medical Microbiology · doi:10.1016/0928-8244(93)90036-4 · Cited by 54
Ghannoum, M. A., Roilides, E., Katragkou, A., Petraitis, V., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ815 · Cited by 54
Shields, R. K., Kline, E. G., Healey, K. R., Kordalewska, M., Perlin, D. S., Nguyen, M. H., & Clancy, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01692-18 · Cited by 52
Sensing of the Microbial Neighborhood by Candida albicans
Mallick, E. M., & Bennett, R. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003661 · Cited by 47
El-Azizi, M., Farag, N. S., & Khardori, N. M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0083-3 · Cited by 44
Sakagami, T., Kawano, T., Yamashita, K., Yamada, E., Fujino, N., Kaeriyama, M., Fukuda, Y., Nomura, N., Mitsuyama, J., Suematsu, H., et al. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.10.007 · Cited by 44
Lepak, A. J., Nett, J. E., Lincoln, L., Marchillo, K., & Andes, D. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1311-1319.2006 · Cited by 42
Faria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. T., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2471-1 · Cited by 41
Antifungal use in intensive care units
Meyer, E., Schwab, F., Gastmeier, P., Rüden, H., & Heininger, A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm255 · Cited by 33
Clinical relevance of resistance to antifungals
Rodríguez-Tudela, J. L., Alcázar‐Fuoli, L., Cuesta, I., Alastruey‐Izquierdo, A., Monzón, A., Mellado, E., & Cuenca‐Estrella, M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70010-4 · Cited by 29
Kritikos, A., Neofytos, D., Khanna, N., Schreiber, P. W., Boggian, K., Billé, J., Schrenzel, J., Mühlethaler, K., Zbinden, R., Bruderer, T., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.05.012 · Cited by 28
Tanner, L., Evans, J. C., Seldon, R., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01010-19 · Cited by 27
Biofilms and Antifungal Resistance
Fox, E. P., Singh-Babak, S. D., Hartooni, N., & Nobile, C. J. (2015) · Caister Academic Press eBooks · doi:10.21775/9781910190012.04 · Cited by 17
Farnesol and Candida albicans: Quorum Sensing or Not Quorum Sensing?
Krom, B. P., Levy, N., Meijler, M. M., & Jabra‐Rizk, M. A. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201500025 · Cited by 15
Cited by
Recent Advances in the Allergic Cross-Reactivity between Fungi and Foods
Xing, H., Wang, J., Sun, Y., & Wang, H. (2022) · Journal of Immunology Research · doi:10.1155/2022/7583400 · Cited by 92
Development and research progress of anti-drug resistant fungal drugs
Cui, X., Wang, L., Lü, Y., & Yue, C. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.08.004 · Cited by 85
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Kim, J.-S., Lee, K.-T., & Bahn, Y.-S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02152-23 · Cited by 24
Zou, P., Liu, J., Li, P., & Luan, Q. (2024) · Antibiotics · doi:10.3390/antibiotics13060521 · Cited by 12
Metadata
- Authors
- Pereira, R., Santos Fontenelle, R. O., Brito, E. H. S., & Morais, S. M.
- Venue
- Journal of Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-09
- Volume
- 131
- Issue
- 1
- Pages
- 11-22
- ISSN
- 1364-5072 (ISSN-L)
- 1365-2672
- OpenAlex
- W3107998850
- Cited by
- 368
- References
- 112
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.